Roxanne Valentino, MD
Sleep Medicine · Hendersonville, TNNPI 1104868678
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,547 of the $2,066 with a category attached, or 74.9%. Inspire Medical Systems, Inc. accounts for 77.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $794, 2.2 times the $369 reported in 2021.
Across 41 payments — averaging $50.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Jazz Pharmaceuticals Inc.$368
- ZOLL Respicardia, Inc.$45
- Lilly USA, LLC$31
- Harmony Biosciences LLC$14
What the payments were for
- Travel & lodging$51925%
- Food & beverage$1,54775%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 22 | $1,608 |
| Jazz Pharmaceuticals Inc. | 13 | $368 |
| ZOLL Respicardia, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $31 |
| Harmony Biosciences LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,066 in reported general payments places this provider in the 60th percentile of 41 sleep medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ramelteon | 15 | $1,312 |
| Armodafinil | 15 | $1,286 |
| Modafinil | 20 | $1,167 |
| Gabapentin | 53 | $687 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 45 | $575 |
| Eszopiclone | 18 | $469 |
| Trazodone Hcl | 39 | $331 |
| Clonazepam | 36 | $214 |
| Ropinirole Hcl | 16 | $211 |
| Quetiapine Fumarate | 17 | $206 |
| Mirtazapine | 14 | $135 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Hendersonville
- Bijoy JohnBrentwood$38K
- Kelly CardenNashville$24K
- Martha HagamanFranklin$20K
- John DenglerJohnson City$19K
- Prashant JamesKnoxville$11K
- Kevin MartinolichKnoxville$9K
- Merrill WiseMemphis$7K
- Christopher NolteKnoxville$7K
- Nancy LambCordova$5K
- Melissa KhalilJohnson City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.